Journal of Cancer Sciences
Review Article
Artificial Intelligence in Radiation Oncology: Applications and Future Direction
Wang T1,3, Goel HL1-3, Ding L1, Bradford C1, Khalifeh A1, Liu F1, Fan Y1, Kuo I-L1, Larosa S1, Yancey J1, Jones G1, Harris D1, Bishop-Jodoin M1, Smith K1, Iandoli M1, Laurie F1, Goel S2 and FitzGerald TJ1*
1Department of Radiation Oncology, University of Massachusetts Chan Medical
School, Worcester, MA, USA
2Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA
3Co-first Authors
2Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA
3Co-first Authors
*Address for Correspondence:Thomas J FitzGerald, Department of Radiation Oncology, University of
Massachusetts Chan Medical School, Worcester, MA, USA E-mail Id: TJ.FitzGerald@umassmemorial.org
Submission:28 February, 2024
Accepted:27 March, 2024
Published:02 April, 2024
Copyright:© 2024 Wang T, et al. This is an open access article
distributed under the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited.
Abstract
The practice of radiation oncology is changing at a rapid
pace. As models of care and department reimbursement change,
departments are evaluating an increasing number of patients with
complex medical backgrounds which must be acknowledged as
increasing difficult treatment plans are developed. With altered
fractionation strategies, compressed fractionation treatment delivery,
and highly sophisticated radiation therapy treatment technology,
radiation therapy has evolved into a highly rigorous discipline applying
multiple overlapping image datasets to define targets of interest with
sophisticated image guidance tools to ensure accuracy of therapy.
Integrated with biomarkers associated with treatment response and
therapeutic resistance, radiation therapy can be delivered to tumor
with altered doses to image-guided subsets of disease. The datasets
now required to generate radiation oncology treatment plans are
becoming increasingly large and complex. Ultimately, artificial
intelligence models will mature to ensure accuracy and consistency to
department workflows and therapeutic decisions including contouring
and treatment planning. Artificial intelligence can and will be applied
to all elements of daily patient care as well as clinical translational
research. In this paper, we explore how multiple components of
artificial intelligence will support the radiation oncology work force
and therapy-guided clinical trials moving forward.